EVH Evolent Health Inc - Class A

Price (delayed)

$4.765

Market cap

$538.95M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$4.46

Enterprise value

$1.36B

Relative Growth: Rel. Growth:
Relative Strength: Rel. Strength:
Relative Valuation: Rel. Valuation:
Relative Profitability: Rel. Profitability: 5

Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers ...

Highlights
The revenue has grown by 14% YoY and by 12% from the previous quarter
The debt has decreased by 10% YoY
The EPS has shrunk by 184% YoY
The company's equity has shrunk by 56% YoY and by 2.7% QoQ

Key stats

What are the main financial stats of EVH

EVH stock price

How has the Evolent Health stock price performed over time
Intraday
-4.51%
1 week
4.96%
1 month
12.12%
1 year
7.08%
YTD
19.13%
QTD
36.53%

Financial performance

How have Evolent Health's revenue and profit performed over time
Revenue
$2.34B
Gross profit
$350.28M
Operating income
-$429.92M
Net income
-$507.69M
Gross margin
15%
Net margin
-21.7%
The gross margin has contracted by 18% YoY and by 13% from the previous quarter
The revenue has grown by 14% YoY and by 12% from the previous quarter
The net margin has increased by 10% QoQ
The operating margin has increased by 9% from the previous quarter

Price vs fundamentals

How does EVH's price correlate with its fundamentals

Growth

What is Evolent Health's growth rate over time

Valuation

What is Evolent Health stock price valuation
P/E
N/A
P/B
1.44
P/S
0.23
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
0.58
The EPS has shrunk by 184% YoY
The company's equity has shrunk by 56% YoY and by 2.7% QoQ
EVH's price to book (P/B) is 42% lower than its 5-year quarterly average of 2.6 but 37% higher than its last 4 quarters average of 1.1
The price to sales (P/S) is 83% lower than the 5-year quarterly average of 1.4 but 20% higher than the last 4 quarters average of 0.2
The revenue has grown by 14% YoY and by 12% from the previous quarter

Efficiency

How efficient is Evolent Health business performance
The ROE has contracted by 29% from the previous quarter
The ROS rose by 10% QoQ
Evolent Health's return on assets has decreased by 6% QoQ
EVH's return on invested capital is down by 5% since the previous quarter

Dividends

What is EVH's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for EVH.

Financial health

How did Evolent Health financials performed over time
The company's total assets is 23% higher than its total liabilities
The company's total assets fell by 20% YoY
The company's current ratio fell by 5% YoY
The debt is 161% higher than the equity
EVH's debt to equity has surged by 102% year-on-year and by 3.2% since the previous quarter
The company's equity has shrunk by 56% YoY and by 2.7% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.